The total ethanolic extract (TEE) of Carduncellus mareoticus (Del.) Hanelt showed antioxidant and antihyperlipidemic activities, which were attributed to the ethyl acetate fraction (EAF). Also TEE showed potent cytotoxic activity against a cervix cancer cell line (IC 50 = 5 µg/mL) and moderate activity against a breast cancer cell line. Chemical investigation of EAF led to the isolation of a new flavonoid, 8-hydroxy-5-methoxyluteolin 7-O-β-D-glucopyranoside (11), along with ten known metabolites (1-10). Three of these compounds, isorhamnetin 3-O-β-D-glucopyranoside (7), luteolin 3'-O-β-D-glucopyranoside (8), and eriodictyol 7-O-β-D-glucopyranoside (9) are reported for the first time from the genus Carduncellus, and two compounds, chrysoeriol 7-O-β-D-glucopyranoside (6), and luteolin 7-O-β-D-glucopyranoside (10), for the first time from C. mareoticus. The rest of the isolated compounds, chrysoeriol (1), luteolin (2), quercetin (3), kaempferol 3-O-α-Larabinopyranoside (4), and kaempferol 3-O-β-D-glucopyranoside (5) have been previously reported from the genus.
The EAF of the total ethanol extract (TEE) of the aerial parts of C. mareoticus, after chromatographic separation, gave a new flavonoid glycoside (11) , in addition to 3 known aglycones (1-3), and 7 monoglycosides (4) (5) (6) (7) (8) (9) (10) . The structures of the known compounds were established by comparison of their 11 spectral data (UV, 1 H and 13 C NMR) with those from the literature [9] [10] [11] and their identities were further confirmed through co-chromatography with authentic samples.
Compound 11 was obtained as a yellow powder. A hypsochromic shift of band I in the UV spectrum on addition of HCl (-63 nm), as well as a bathochromic shift (+25 nm) in band I with boric acid, confirmed the presence of an ortho-dihydroxy pattern in ring B. The lack of shift in band II on addition of NaOAc indicated an OH group at position 7. The 1 H NMR spectrum showed protons characteristic for ring A, one singlet proton at δ 6.37, assigned to H-6, while the signal for H-8 was absent, which confirmed substitution of H-8. The downfield shift of H-6 confirmed the presence of a sugar on C-7. In addition, a three proton methoxy singlet at δ 3.8 can be assigned to C-5 (position 5 shown to be occupied from the UV spectrum). The ring B protons are represented by H-5' upfield from H-2', and the 6' protons at δ 6.93, as a doublet with J (ortho) = 8.4
Hz. H-2' appeared as a broad singlet at δ 7.79, while H-6' displayed as a broad doublet at δ 7.7 with a J-value of 8.4 Hz. Ring C showed the H-3 proton only at δ 6.8 as a singlet. The anomeric proton of the sugar moiety was assigned at δ 5.01 (a typical value for 7-O-glycosidation) [9] , with a J-value characteristic of a β-configuration (6.9 Hz).
The 13 C NMR spectrum showed the characteristic 15 carbon resonances of a luteolin 7-O-substituted aglycone [10, 11] , together with six carbon resonances typical for a glucopyranoside moiety. The intrinsic downfield shift of C-8 (at δ 128.82), with ∆ of about + 34 ppm, was interpreted as being due to the presence of a hydroxyl group on C-8 [10, 11] . The methoxy group signal was observed at δ 56.29 to confirm its position on C-5 (if present on C-8, the methoxy group should be displayed at δ 60) [10, 11] . Based on the previous discussion, compound 11 was identified as 8-hydroxy-5-methoxyluteolin 7-O-β-D-glucopyranoside.
The LD 50 values of both TEE and TAE of C. mareoticus aerial parts were 3.6 and 3.2 g/kg respectively. A test on their acute antihyperglycemic effects ( Table 1 ) was performed to assess the antiperoxidation properties of C. mareoticus in alloxan-induced diabetic rats. Unlike C. eriocephalus, TEE and TAE lacked any antihyperglycemic effect. GSH (glutathione) is the first line of defense against a prooxidant status [12] ; it decreased significantly in plasma of diabetic rats. GSH was evaluated after administration of different fractions of C. mareoticus using vitamin E as reference drug. TEE and TAE significantly increased GSH levels, which could be attributed to its high flavonoid content [13] . The antioxidant activity of flavonoids is based upon the structure-activity relationship, i.e. the π-bond conjugation over A-and B-rings through a 4-keto group, 2,3-double bond and the aromatic-OHs. This conjugation is responsible for stabilization of the aryloxy radical after hydrogen donation in the free radical scavenging process [14] . TEE and TAE decreased the cholesterol level after 8 weeks by 25% and 22%, respectively ( Table 2) . EAF was the most effective fraction; it decreased the cholesterol level by 40%, an effect that is not significantly different from that of Simvastatin (53 % decrease). The n-hexane fraction (HF) was the least effective.
As shown in Table 2 , TAE is markedly decreased the triglycerides level by 31%. EAF was the most potent fraction, decreasing the triglycerides level by 39%, an effect not significantly different from that of Simvastatin, which decreased it by 43.1% after 8 weeks. Both TEE and TAE increased the level of HDL-c by 76% ( Table 3 ). All tested fractions were very potent and were not significantly different from Simvastatin. EAF proved to be the most effective fraction increasing the level of HDL-c by 77%.
Both TEE and TAE decreased the level of LDL-c by 49% after 8 weeks (Table 3 ). EAF was the most effective fraction (70% decrease), being not significantly different in its effects from the reference drug (Simvastatin), which decreased LDL-c by 83% after 8 weeks.
TEE and TAE decreased the risk factor (LDLc/HDL-c ratio) by 71% and 73%, respectively (Table 3) . EAF was the most potent, significantly reduced LDL-c/HDL-c ratio by 85%, which was not significantly different from that of Simvastatin (reduced risk factor by 91.5%).
Potential cytotoxicity of TEE was assessed [15] on five cancer cell lines, U251 (brain cancer), MCF7 (breast cancer), Hela (cervix cancer), H 460 (lung cancer), and HEPG2 (liver cancer). The relation between the surviving cell fraction and drug concentration was determined. It was obvious that TEE showed potent cytotoxic activity against the cervix cancer cell line (IC 50 = 5 µg/mL) and moderate activity against the breast cancer cell line. For this reason, the different fractions of C. mareoticus were tested for their cytotoxic activities on cervix and breast cancer cell lines. The results revealed that all of the tested fractions lack cytotoxic activity against the tested cell lines. Consequently, the use of the total ethanol extract was preferred as an anti-tumor agent in cervix and breast cancer. The better performance of the whole ethanol extract may be due to synergistic effects of the different constituents present. a Significantly different from normal value at P = 0.01. b Significantly different from hypercholesterolemic value at P = 0.01. C Significantly different from Simvastatin value at P = 0.01. 
Experimental
General: Melting points were determined on a Kofler hot stage microscope. UV spectra were measured using a Shimadzu UV 240 (P/N 204-58000) spectrophotometer, and NMR spectra with JEOL GLM (Japan) ( 1 H NMR, 300 MHz; 13 C NMR, 75 MHz) and JEOL JNM ECA 500 instruments (Japan) ( 1 H NMR, 500 MHz; 13 C, 125 MHz). The NMR spectra were recorded in DMSO-d 6 , CD 3 OD or CDCl 3 , and chemical shifts were given in δ (ppm) relative to TMS as internal standard. 
Extraction and isolation:
Air-dried powdered flowering aerial parts of C. mareoticus (2 Kg) were extracted with 70% EtOH (4 x 2.5 L) under reflux (70 o C). The ethanolic extract was evaporated under reduced pressure to give 120 g of dark green residue, which was suspended in water (200 mL) and partitioned successively with n-hexane (4 x 300 mL), chloroform (4 x 300 mL), EtOAc (5 x 300 mL), and n-butanol (5 x 300 mL) to yield, after evaporation, dry residues of 20 g (n-hexane fraction, HF), 14 g (chloroform fraction, CF), 11 g (EAF), and 18 g (nbutanol fraction, BF). For pharmacological study, another 500 g of the dried aerial parts of the plant were extracted and fractionated in the same way.
In addition, 100 g of powdered plant material was percolated with 500 mL hot water, followed by evaporation under reduced pressure. The residue was dissolved in sterile water before administration to rats. EAF (11 g) was chromatographed over silica gel 60 H (Sigma) VLC (Ø10 x 20 cm, 100 g) with CHCl 3 , CHCl 3 -EtOAc mixtures, EtOAc and EtOAc-MeOH mixtures to gradually increase the polarity, up to pure methanol. Fractions (100 mL each) were collected and monitored by TLC under UV-light (245 nm and 365 nm), and p-anisaldehyde was used for detection. Similar fractions were pooled to give 5 collective fractions. Fractions 1 (3 g), 2 (1.5 g), 3 (2.3 g), 4 (1.5 g), and 5 (500 mg) were subjected separately to CC on Sephadex LH-20, with MeOH as eluent. Fraction 1 was rechromatographed by prep-PC using Whatmann No. 3 paper with (S1) n-BuOH-HOAc-H 2 O (4:1:5, top layer) to give compounds 1 (12 mg), 2 (13 mg), and 3 (18 mg). Fractions 2 and 4 were rechromatographed separately by prep-TLC using silica gel 60 G (Sigma) (CHCl 3 : MeOH, 8:2), and the eluted fractions were purified by CC on Sephadex LH-20 with MeOH as eluent to give compounds 4 (12 mg), and 5 (10 mg) from fraction 2, and 8 (10 mg), and 9 (18 mg) from fraction 4. Pharmacological tests: Adult male albino rats (130-150 g) were obtained from the animal-breeding unit of the National Research Center, Dokki, Giza, Egypt. Rats were fed on a standard laboratory diet and water ad libidum. One part of rats was fed on a high fat diet composed of the normal diet supplemented with 0.2% cholic acid with 1% cholesterol and 10% fat; this part was kept for the antihyperlipidemic study [16] . Doses of the drugs were calculated according to Paget and Barnes [17] , and were administrated orally by gastric tube. The chemicals used in this study were: Alloxan (Sigma Co., USA); Simvastatin [(Zocor ® ), Global Napi Pharmaceutical, Egypt]; Vitamin E (Pharco Pharmaceutical Co., Egypt), and Metformin [(Cidophage) ® , CID Co., Egypt]. Kits for biochemical assessment of glucose, cholesterol, triglycerides, LDL-c and HDL-c were from Biomerieux (France), and glutathione kits from Wak Company (Germany).
LD 50 values of both ethanol and aqueous extracts, previously prepared from C. mareoticus, were determined following Karber's procedures [18] .
For assessing antihyperglycemic effect, 50 adult, male albino rats were used in the experiment and divided into 5 groups. One group was kept as the control. A single dose of alloxan (150 mg / kg b. wt.) was injected intraperitoneally into individuals of the remaining groups to induce hyperglycemia [19] . The second group was kept as the diabetic control, and the third group was given 150 mg/kg Metformin orally every day. The fourth and fifth groups received oral daily doses of 100 mg/kg of the aqueous and ethanol extracts of C. mareoticus. Blood glucose [20] and GSH levels [21] were measured.
The antihyperlipidemic effect of the tested extract was evaluated and compared with that of Simvastatin. Ninety adult male albino rats were divided into 9 groups. One group received 1 mL saline and was kept as the control. Hyperlipidemia was induced in the remaining 8 groups by feeding the rats for 2 months on a high fat diet, according to the procedures of Ney et al. [16] . Hyperlipidemia was assessed by measuring serum cholesterol [22] , triglycerides [23] , HDL-c (high density lipoprotein), and LDL-c (low density lipoprotein) [24] using Biomerieux kits. Animal groups were divided as follows: the first group served as the hypercholesterolemic control. The second group received Simvastatin (100 mg/kg b. wt. daily), the third to eighth groups received daily an oral dose (100 mg/kg) of the ethanol, aqueous, n-hexane, chloroform, ethyl acetate and n-butanol fraction, respectively.
All data are expressed as mean±S.E. and the statistical significance was evaluated by One-Way Analysis of Variance (ANOVA) [25] . The values were considered to be significantly different when P values were less than 0.05.
